| Literature DB >> 27706084 |
Abdullatif Azab1, Ahmad Nassar2, Abed N Azab3,4.
Abstract
This article presents highlights of the published literature regarding the anti-inflammatory activities of natural products. Many review articles were published in this regard, however, most of them have presented this important issue from a regional, limited perspective. This paper summarizes the vast range of review and research articles that have reported on the anti-inflammatory effects of extracts and/or pure compounds derived from natural products. Moreover, this review pinpoints some interesting traditionally used medicinal plants that were not investigated yet.Entities:
Keywords: anti-inflammatory activity; natural products; plant extract; pure compounds
Mesh:
Substances:
Year: 2016 PMID: 27706084 PMCID: PMC6274146 DOI: 10.3390/molecules21101321
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Structures of ganoderic acid A (A) and ergosta-4-6-8(14),22-tetraen-3-one (B).
Figure 2Structure of some cyathins isolated from mushrooms.
Figure 3Structure of agrocybin.
Summary of selected review articles (2005–2016) reporting on the anti-inflammatory effects of plant products *.
| Main Theme of the Article | Major Method(s) of Testing | Major Active Materials/Compounds | Main Effects on Inflammation * | Ref. |
|---|---|---|---|---|
| Brazilian plants | Inflammation induction in rats and mice (e.g., by carrageenan) | Plants parts, various extracts, chromatographic fractions | Significant inhibition of COX and 5-LOX activity; reduction in edema volume | [ |
| Plant-based foods | Plant-based food consumption in humans | Carotenoids, flavonoids, phenolic acids, monoterpenes, sulfides | Reduction in C-reactive protein (CRP) and IL-6 levels; inhibition of NFκB | [ |
| Plant natural products | Various in vitro and in vivo models of inflammation (e.g., lipopolysaccharide [LPS]-induced) and cancer | Polyphenols, capsaicin, curcumin, ascorbic acid, indol-3-carbinol, geraniol, sulphoraphane, gingerol, lycopene, deoxyelephantophin | Significant reduction in cytokines levels; inhibition of COX-2, iNOS, NFκB and STAT (signal transducers and activators of transcription) activity | [ |
| Plant barks | Various inflammation models in vivo (e.g., carrageenan-induced paw edema) | Various extracts, oleanolic acid, polyphenols, coumarin, β-amyrin, ursolic acid, β-sitosterol | Significant inhibition of COX and iNOS activity; attenuation of paw edema | [ |
| Medicinal plants (General) | Various inflammation models in vivo (e.g., carrageenan-induced paw edema) | Various extracts; ambrosanolide, betulinic acid, ardisiaquinone G, polyphenols and others | Inhibition of COX, iNOS, 5-LOX and PLA2 activity; attenuation of paw edema | [ |
| Herbal drugs (medicinal plants) | Various in vitro and in vivo (animals) models of inflammation; clinical trials in humans including safety and efficacy measures | Detailed compound families (e.g., alkaloids, glycosides, terpenoids, resins, essential oils, fatty acids, flavonoids, polysaccharides, phenolic compounds, steroids, cannabinoids, glycoproteins) | Significant reduction in cytokines, LTs, PGs and NO levels; inhibition of COX, iNOS, 5-LOX, PLA2 and NFκB activity; in humans: analgesic effects in different pain states, reduction of edema, attenuation of inflammatory measures | [ |
| Virgin olive oil | Various in vitro and in vivo models of inflammation; clinical trials in humans | The phenolic compound oleocanthal | Reduction in cytokines, CRP, LTs, and PGs levels; inhibition of COX, iNOS, 5-LOX and NFκB activity | [ |
| Medicinal plants | Various in vitro and in vivo models of inflammation | Whole plant or parts; alkaloids, glycosides, essential oils, fatty acids, flavonoids, nyctanthic acid, phyllanthin, and many others | Analgesic effects and reduction of inflammatory measures | [ |
| Mangrove plants | Various in vitro and in vivo models of inflammation | Various extracts, pure compounds such as: agallochaol O, eugenol, mimosol D, calophyllolide | Reduction in cytokines, LTs, NO and PGs levels; inhibition of COX, iNOS, 5-LOX and NFκB activity | [ |
| Herbal plants | Various in vitro and in vivo models of inflammation | Various extracts, plants parts, resins | Significant reduction in cytokines, LTs, NO and PGs levels; inhibition of COX, iNOS and 5-LOX activity | [ |
| Marine natural products from soft corals | Various in vitro and in vivo models of inflammation (e.g., LPS-induced inflammation) | Sesquiterpenoids, diterpenoids, steroids, ceramide, cerebrosides, and many others (a comprehensive review with 339 structures) | Reduction in cytokines, NO and PGs levels; inhibition of COX and iNOS activity | [ |
| Marine natural products of algal origin | Various in vitro and in vivo models of inflammation (e.g., LPS-induced inflammation) | Various extracts and pure compounds such as neorogioltriol, (12 | Reduction in IL-6, TNF-α, NO and PGs levels; inhibition of COX, iNOS, NFκB and STAT activity | [ |
| Ethnobotanical plants | Carrageenan-induced paw edema | Various extracts | Significant reduction in edema volume; effects were similar to those of other anti-inflammatory drugs such as valdecoxib, sulindac, aspirin, diclofenac, ibuprofen, phenylbutazone and indomethacin | [ |
| Plant-derived compounds | Various in vitro and in vivo models of inflammation; pre-clinical tests and clinical trials in humans | Curcumin, colchicine, resveratrol, capsaicin, epigallocatechin-3-gallate, quercetin | Reduction in cytokines, LTs and PGs levels; inhibition of COX-2, 5-LOX and NFκB activity; in humans: attenuation of inflammatory measures such as CRP, IL-1β, IL-6, and TNF-α | [ |
| Active organosulfur compounds in garlic | Various in vitro and in vivo animals models (LPS-induced inflammation); studies in human volunteers and pre-clinical studies | Ajoene, diallyl sulfide, diallyl disulfide, allylmethyl sulfide, | Anti-inflammatory: reduction in PGs, NO, IL-1β, IL6 and TNF-α levels; increase in IL-10 levels; inhibition of COX-2, iNOS and NFκB activity Pro-inflammatory: opposite effects of the mentioned above | [ |
| Active organosulfur compounds and extracts of garlic | Various in vitro and in vivo animals models (e.g., LPS-induced inflammation); studies in humans | Aqueous, oil, chloroform and n-hexane extracts, as well as compounds in previous raw | Anti-inflammatory: reduction in IL-1β, IL-6 and TNF-α levels; increase in IL-10 levels; inhibition of NFκB activity Pro-inflammatory: increase in NO, IFN-γ and TNF-α levels | [ |
| Indian medicinal plants | Various in vitro and in vivo models | Polyphenols, lignans, anthraquinones, flavonoids, alkaloids, terpenoids, saponins, polysaccharides | Reduction in TNF-α and other cytokines levels; inhibition of PLA2 activity; general–anti-inflammatory, analgesic and anti-allergic effects | [ |
| Marine diterpenoids | Various in vitro and in vivo models (e.g., LPS-induced inflammation) | Eunicellane, briarane, cembrane and other diterpenoids | Significant reduction in IL-6, TNF-α, NO, PGs and LTs levels; significant inhibition of COX-2, iNOS, 5-LOX and NFκB activity, some of the effects were comparable to those of anti-inflammatory drugs such as indomethacin | [ |
| Citrus flavonoids | Various in vitro and in vivo animal models (e.g., LPS-induced inflammation), healthy human volunteers | Hesperidin and hesperetin—two major flavonoids of citrus | Reduction in IL-1β, IL-6, TNF-α, NO and PGs levels; inhibition of COX-2, iNOS and NFκB activity; reduction in plasma CRP levels in humans | [ |
| Plant polyphenols | Various in vitro and in vivo animal models (e.g., LPS-induced inflammation) | Plant polyphenols such as curcumin, apigenin, quercetin, | Reduction in IL-1β, IL-6, TNF-α, NO and PGs levels; inhibition of COX-2, iNOS and NFκB activity | [ |
| Marine natural products | Various in vitro and in vivo animal models (e.g., LPS or carrageenan-induced inflammation) | Detailed structures of 35 marine compounds such as steroids, fatty acids, diterpenes, sesquiterpenoids, alkaloids and polysaccharides | Significant reduction in IL-1β, IL-6, TNF-α, NO and PGs levels; significant inhibition of COX-2, iNOS and NFκB activity | [ |
| Medicinal plants | Various in vitro and in vivo animal models (e.g., LPS-induced inflammation) | Isogarcinol, andrograpanin, hinokitiol, tectorigenin, α-iso-cubebene, schisantherin A, psoralidin, formosumone A, isofraxidin, maslinic acid, mangiferin | Reduction in IL-1β, IL-6, TNF-α, NO and PGs levels; inhibition of COX-2 and iNOS activity | [ |
| LPS-induced inflammation in vitro (cell lines and primary cells); arachidonic acid-induced inflammation and edema in mice ear; randomized, double-blind trial in patients with osteoarthritis | Catethin, epicatechin, flavonoids | In-vitro studies in cells—a mixture of | [ |
* In this table, the word “significant” indicates that the P value for the difference between the tested groups is less than 0.05 or even smaller.
Summary of selected research articles reporting on the anti-inflammatory effects of plant products.
| Extracting Solvent(s) | Major Method(s) of Testing | Plant Species | Main Effects on Inflammation * | Ref. |
|---|---|---|---|---|
| 80% EtOH in H2O | Carrageenan-induced paw edema in rats (for assessing inflammation) | 75 species of medicinal plants that grow in Italy | Four species caused a significant reduction in paw edema similar to that seen under treatment with indomethacin. Other species exerted a less prominent edema-reducing effect | [ |
| H2O | Carrageenan-induced paw edema in rats | Five species of Costa Rican medicinal plants: | Four species caused a significant reduction in paw edema, similar to that seen under treatment with indomethacin | [ |
| 10% EtOH in H2O | Hot-plate method for assessing analgesia; carrageenan-induced paw edema | A significant reduction in paw edema and an analgesic effect, similar to that of diclofenac | [ | |
| H2O | LPS-induced inflammation in a macrophage cell line (RAW 264.7 cells) | A significant reduction in IL-6, TNF-α, NO and PGE2 levels; decrease in iNOS expression; effects were more prominent than those of indomethacin | [ | |
| 70% MeOH in H2O | Carrageenan-induced paw edema in chicks | A significant dose-dependent reduction in paw edema which was stronger than that seen under treatment with aspirin | [ | |
| Croton oil-induced ear edema in mice | [ | |||
| H2O, | Hot-plate method in mice; cotton pellet granuloma and carrageenan-induced paw edema in rats | The H2O and BuOH extracts had a marked analgesic effect; both extracts significantly and dose-dependently reduced pellet granuloma and paw edema-effects were comparable to those of indomethacin | [ | |
| CHCl3, MeOH, EtOAc, | Carrageenan-induced paw edema in mice | A significant reduction in paw edema similar to that seen under treatment with diclofenac | [ | |
| H2O | Carrageenan-induced paw edema and yeast-induced pyrexia in rats | A significant reduction in paw edema which was stronger than that of aspirin; attenuation of hyperthermia (fever) | [ | |
| EtOH | Carrageenan-induced paw edema and cotton pellet-induced granuloma in rats | A significant reduction in paw edema and pellet granuloma; effects were similar to those of indomethacin | [ | |
| MeOH | In-vitro assays for measuring neutrophils inflammation and lipoxygenase activity | Three compounds had a significant anti-inflammatory activity; two compounds inhibited the activity of lipoxygenase | [ | |
| Essential oils | LPS-induced inflammation in RAW 264.7 cells | [ | ||
| H2O | Ethyl phenylpropiolate and arachidonic acid-induced ear edema, carrageenan-induced paw edema, and cotton pellet-induced granuloma in rats | Significant inhibition of ear inflammation and a reduction in paw edema and pellet granuloma—effects were similar to those of aspirin; the extract exerted an analgesic effect | [ | |
| MeOH | LPS-induced inflammation in RAW 264.7 cells | A significant, dose-dependent reduction in PGE2 and NO levels; a significant decrease in COX-2 and iNOS expression | [ | |
| MeOH | Acetic acid-induced writhing in mice; carrageenan-induced paw edema in rats | A non-significant reduction in paw edema; a significant analgesic effect similar to that of diclofenac | [ | |
| MeOH | Hot-plate method in mice; cotton pellet granuloma and carrageenan-induced paw edema in rats | Anti-inflammatory and analgesic effects, a significant reduction in paw edema; effects were similar to those of ibuprofen | [ | |
| 70% MeOH in H2O, then, in different solvents | LPS-induced inflammation in RAW 264.7 cells | The aqueous extract caused a significant reduction in NO levels; and, a significant dose-dependent decrease in COX-2, IL-1β, IL-6 and TNF-α expression | [ | |
| H2O, EtOH | Inflammation induced by LPS and INF-γ in RAW 264.7 cells | 40 Chinese plant species | Several extracts caused a significant reduction in NO and TNF-α levels | [ |
| H2O, EtOH | Inflammation induced by LPS and INF-γ in J774A.1 cells | 13 Chinese plant species and two fungi | Some extracts caused a significant reduction in NO and TNF-α levels | [ |
| EtOH | Carrageenan-induced paw edema in rats | A significant reduction in paw edema | [ | |
| Cotton pellet granuloma and carrageenan-induced paw edema in rats | A significant decrease in paw edema and a modest reduction in pellet granuloma; effects were similar to those of indomethacin | [ | ||
| EtOH | Carrageenan-induced paw edema in rats | A significant decrease in paw edema which was similar to that of indomethacin | [ | |
| MeOH | Hot-plate test & acetic acid-induced writhing in mice; carrageenan-induced paw edema in rats; yeast-induced pyrexia in rats | Significant dose-dependent analgesic effect, anti-inflammatory effect (reduction in paw edema) and antipyretic effect; effects were similar to those of reference drugs such as ketorolac and paracetamol | [ | |
| H2O | Carrageenan-induced paw edema in mice | A significant reduction in paw edema; effect was similar to that of indomethacin | [ | |
| EtOH | 12-O-tetradecanoylphorbol-acetate-induced ear edema in mice | A significant dose-dependent reduction in ear edema; a decrease in IL-1β levels and leukocytes migration to the tissue; effects were less potent than those of dexamethasone | [ | |
| Extra virgin olive oil | Acetic acid-induced writhing and formalin tests in mice; carrageenan-induced paw edema in rats | A significant analgesic effect similar to that of aspirin; a significant reduction in paw edema similar to that seen under treatment with dexamethasone | [ | |
| 80% MOH in H2O | Collagen-induced arthritis in mice | Polyphenol extract of extra virgin olive oil ( | A significant reduction in joint edema and bone loss; a significant decline in leukocytes migration; a decrease in PGE2, IL-1β, IL-6 and TNF-α levels; a significant reduction in COX-2 expression and NFκB activity, among other anti-inflammatory effects | [ |
| EtOH and fractionation with | A significant reduction in protein levels of multiple pro-inflammatory mediators (e.g., IL-1β, IL-6, IL-8) and a decrease in their gene expression | [ | ||
| EtOH | Assessment of 5-LOX activity in lung cancer cell line A549 | A significant reduction in 5-LOX activity | [ | |
| EtOH | Adjuvant-induced arthritis in mice | A significant decrease in CRP, IL-1β, IL-6 and TNF-α levels; a significant reduction in arthritis | [ | |
| Acetone | LPS-induced inflammation in RAW 264.7 cells; assessment of 15-LOX activity | 25 South African plant species | A significant reduction in NO levels; significant inhibition of 15-LOX activity | [ |
| H2O | Carrageenan-induced paw edema in mice | A significant reduction in TNF-α levels; a significant decline in leukocytes migration; effects were comparable to those of indomethacin | [ | |
| EtOH and fractionation with | Carrageenan-induced paw edema in mice | A significant reduction in paw edema which was similar to that seen under treatment with indomethacin | [ | |
| EtOH then petroleum ether | Human peripheral blood cells stimulated with different antigens | A significant dose-dependent reduction in NO levels; a decrease in leukocytes count | [ | |
| MeOH | LPS-induced inflammation in RAW 264.7 cells; dextran sulfate sodium-induced colitis in mice | A significant dose-dependent decrease in nitrites, IL-6 and TNF-α levels; a significant reduction in COX-2 and iNOS expression; a significant decline in NFκB activity, among other inflammatory markers that were attenuated | [ | |
| 90% EtOH in H2O | LPS-induced inflammation in human gingival fibroblasts | A significant reduction in IL-6, IL-8 and MCP-1 levels | [ | |
| 70% MeOH in H2O | LPS-induced inflammation in RAW 264.7 cells | A significant dose-dependent decrease in nitrites and TNF-α levels; a significant dose-dependent reduction in COX-2 and iNOS expression | [ | |
| Carrageenan and experimental trauma-induced paw edema in mice and rats | A significant dose-dependent reduction in paw edema which was similar to that seen under treatment with indomethacin | [ | ||
| EtOH, acetone | LPS-induced release of TNF-α in THP-1 cells | Fourteen non-toxic extracts derived from six plants: | Seven active extracts significantly reduced (>80% inhibition) TNF-α production. The effects of the extracts were comparable to that of dexamethasone (0.1 μM); epicatechin, lanceoloside A and rutin significantly decreased the release of TNF-α by approximately 67%, 65% and 42%, respectively | [ |
| CH2Cl2, EtOAc, MeOH | Ear edema in mice; carrageenan-induced paw edema in rats; acetic acid-induced abdominal writhing and alteration of vascular permeability in mice | A significant reduction in ear edema and myeloperoxidase activity in mice and rats (effects were less potent than those of indomethacin); a significant decrease in vascular permeability in mice (effect was comparable to that of indomethacin); a significant anti-nociceptive effect in mice which was comparable to that of indomethacin | [ | |
| MeOH | LPS-induced inflammation in RAW 264 cells | A significant decrease in NO, PGE2, IL-6 and TNF-α levels; a significant increase in heme oxygenase-1 expression, suggesting enhanced anti-inflammatory activity | [ | |
| H2O, EtOH | A testosterone-induced benign prostatic hyperplasia model in obese rats | A significant reduction in IL-1β, IL-6, NO and TNF-α levels | [ | |
| EtOH in H2O | Formaldehyde and adjuvant-induced Arthritis in rats | A significant reduction in synovial expression of IL-1β, IL-6 and TNF-α; a significant decrease in paw edema; a significant decline in NO levels and leukocytes infiltration to the inflamed joints; all the effects were comparable to those of indomethacin | [ |
* In this table, the word “significant” indicates that the P value for the difference between the tested groups is less than 0.05 or even smaller.
Figure 4Structure of active anti-inflammatory compounds isolated from Eriodictyon angustifolium.
Summary of selected reports of anti-inflammatory activity of pure compounds.
| Compound(s) | Major Method(s) of Testing | Plants with High Concentration of the Compound(s) | Main Effects on Inflammation | Ref. |
|---|---|---|---|---|
| Triterpenes: α/β-amyrin acetate, nimbin, filicene, oleanolic acid | Carrageenan and formaldehyde-induced paw edema in rats | A significant reduction in edema volume; effects were comparable to those of hydrocortisone | [ | |
| Quercetin | Adjuvant and carrageenan-induced arthritis in rats (acute and chronic designs) | A significant reduction in edema volume both in the acute and chronic models; effects were comparable to those of phenylbutazone | [ | |
| Allicin | Carrageenan-induced paw edema in rats | A significant reduction in edema volume which was similar to that of diclofenac | [ | |
| (−)-Myrtenol | Various models in mice: paw edema induced by various compounds, and, carrageenan-induced peritonitis (inflammation); acetic acid-induced writhing, hot-plate test, and, paw licking induced by formalin, glutamate, and capsaicin (nociception) | A significant reduction in edema volume comparable to that of indomethacin; a significant decrease in IL-1β levels; a significant decline in leukocytes count; an significant analgesic effect which was comparable to that of morphine in most tests | [ | |
| Various terpenes and polyphenols | Inflammation induced by LPS in bone marrow derived dendritic cells | A significant reduction in IL-6, IL-12 and TNF-α levels | [ | |
| Ferulic acid | LPS-induced inflammation in macrophages (in-vitro) | A significant decrease in IL-1β and TNF-α expression; a significant reduction in NFκB activity | [ | |
| 3-Hydroxyanthranilic acid | LPS-induced inflammation in RAW 264.7 cells and in mouse peritoneal macrophages | A significant decrease in NO, IL-1β, IL-6 and TNF-α expression; a significant increase in IL-10 expression; a significant reduction in NFκB activity | [ |
Figure 5Structures of oleanolic acid, ursolic acid and cucurbitacin B.
Figure 6Structures of quercetin, allicin, (+)-α-pinene and (−)-myrtenol.